-+ 0.00%
-+ 0.00%
-+ 0.00%

GT BIOPHARMA ANNOUNCES IND SUBMISSION FOR GTB-5550 TRIKE®, A B7-H3-TARGETED NATURAL KILLER (NK) CELL ENGAGER FOR B7-H3 EXPRESSING SOLID TUMOR CANCERS

Reuters·01/15/2026 13:30:58

Please log in to view news